Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Microarray Scanners - Global Strategic Business Report 2026: Capitalize on $1.6 Billion Industry Revenue by 2032 | Thermo Fisher Scientific, Agilent Technologies, Illumina, and Bio-Rad Laboratories Dominate

globenewswire.com
TMO Thermo Fisher Scientific is mentioned as a dominant player in the growing global microarray scanners market, which is projected to reach $1.6 billion by 2032. The article highlights market expansion driven by genomics and precision medicine. A Agilent Technologies is identified as a key company dominating the global microarray scanners market. The market is experiencing growth due to increased investment in genomics and precision medicine, with a projected reach of $1.6 billion by 2032. ILMN Illumina is listed as a dominant company in the expanding global microarray scanners market. The market's growth, driven by genomics and precision medicine, is expected to reach $1.6 billion by 2032. BIO Bio-Rad Laboratories is mentioned as a dominant player in the global microarray scanners market, which is projected to grow significantly to $1.6 billion by 2032. Growth drivers include genomics and precision medicine investments.

Microarray Scanners - Global Strategic Business Report 2026: Capitalize on $1.6 Billion Industry Revenue by 2032 | Thermo Fisher Scientific, Agilent Technologies, Illumina, and Bio-Rad Laboratories Dominate Dublin, Oct. 28, 2026 (GLOBE NEWSWIRE) -- "Microarray Scanners - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

The global microarray scanners market was valued at US$986.1 million in 2025 and is projected to reach US$1.6 billion by 2032, advancing at a compound annual growth rate (CAGR) of 7.2%. Market expansion is being supported by growing investment in genomics, precision medicine, molecular diagnostics, pharmaceutical research and high-throughput biological analysis.

Technology Innovation Strengthens Microarray Scanner Performance

Microarray scanner technology continues to evolve through improvements in imaging resolution, scanning speed, signal-to-noise performance and multiplexing. Pharmaceutical companies, diagnostic laboratories and research institutions are deploying advanced systems for gene expression profiling, genotyping, biomarker discovery, protein analysis and drug development.

Artificial intelligence and machine learning are increasingly being integrated into scanner software to support real-time analytics, pattern recognition and interpretation of complex biological data. These capabilities are especially relevant in oncology research, where microarray platforms support mutation analysis, patient stratification and treatment-response monitoring. Laser-based fluorescence systems and confocal scanning technologies are also improving sensitivity, reproducibility and the detection of low-abundance biological material.

Applications Expand Beyond Traditional Genomics Research

Demand for versatile microarray scanning platforms is rising as life sciences research expands across transcriptomics, proteomics and epigenetics. Additional applications in agricultural genomics, environmental monitoring, infectious disease surveillance, neurogenetics and stem cell research are broadening the global addressable market.

The growth of multiplex assays is encouraging manufacturers to develop systems that accommodate diverse array configurations while maintaining consistent calibration and imaging performance. Interoperability has also become an important purchasing consideration as laboratories adopt cloud-based platforms, open data-processing tools and collaborative analytical environments.

End-Use Demand Shapes Product Development

Diagnostic laboratories represent a key end-use market as personalized medicine and early disease detection increase demand for rapid molecular profiling. Buyers are prioritizing automation, reliability, streamlined workflows and minimal maintenance. Pharmaceutical and biotechnology companies are incorporating microarray scanners into drug discovery, lead identification, validation and diagnostic assay development.

Hospitals and clinical research organizations are also increasing their use of genomic assays to support therapy selection and patient classification. Rising rates of cancer, cardiovascular disease and neurological disorders are reinforcing demand for advanced molecular diagnostic workflows. Government and institutional funding for life sciences research is further supporting scanner adoption, particularly in emerging markets developing genomic research infrastructure.

Microarray Scanners Market Segmentation

Key Market Insights

Principal Microarray Scanners Market Growth Drivers

Market growth is being propelled by automated high-resolution systems, integration with advanced data-analysis platforms and increasing demand for scalable research workflows. Expanding direct-to-consumer genetic testing and personalized healthcare services are creating further commercial opportunities. Microarray analysis is also gaining importance in agriculture, environmental science and biosecurity, extending adoption across new industries and geographic markets.

Report Scope and Strategic Value

The report provides independent annual sales analysis and market forecasts from 2025 through 2032. It examines market trends, growth drivers, restraints, segment performance, regional developments and the competitive landscape. The analysis is designed to help organizations identify revenue opportunities, evaluate investment priorities and support strategic business decisions.

Company coverage includes Agilent Technologies, Arrayit Corporation, Ayoxxa Biosystems, BioMicro Systems, Bio-Rad Laboratories, CapitalBio Technology, Ditabis, Eppendorf, GE Healthcare, Illumina, Innopsys, Molecular Devices, PerkinElmer, Phalanx Biotech Group, Roche Diagnostics, STMicroelectronics and Thermo Fisher Scientific, including Affymetrix and Applied Biosystems.

Domain Expert Insights

Key Attributes

For more information about this report visit https://www.researchandmarkets.com/r/4ldfxc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.